Gender aspects in type 2 diabetes mellitus and cardiometabolic risk

Lipscombe, 2007, Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study, Lancet, 369, 750, 10.1016/S0140-6736(07)60361-4

Choi, 2009, Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998–2005, Diabetes Care, 32, 2016, 10.2337/dc08-2228

Sarwar, 2010, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies, Lancet, 375, 2215, 10.1016/S0140-6736(10)60484-9

Logue, 2011, Do men develop type 2 diabetes at lower body mass indices than women?, Diabetologia, 54, 3003, 10.1007/s00125-011-2313-3

Paul, 2012, Women develop type 2 diabetes at a higher body mass index than men, Diabetologia, 55, 1556, 10.1007/s00125-012-2496-2

Wannamethee, 2012, Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study, Diabetologia, 55, 80, 10.1007/s00125-011-2284-4

Sattar, 2013, Revisiting the links between glycaemia, diabetes and cardiovascular disease, Diabetologia, 56, 686, 10.1007/s00125-012-2817-5

Geer, 2009, Gender differences in insulin resistance, body composition, and energy balance, Gender Medicine, 6, 60, 10.1016/j.genm.2009.02.002

Koster, 2010, Body fat distribution and inflammation among obese older adults with and without metabolic syndrome, Obesity (Silver Spring), 18, 2354, 10.1038/oby.2010.86

Sattar, 2007, Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor, Diabetes, 56, 984, 10.2337/db06-1256

Samuel, 2010, Lipid-induced insulin resistance: unravelling the mechanism, Lancet, 375, 2267, 10.1016/S0140-6736(10)60408-4

Yudkin, 2005, “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease, Lancet, 365, 1817, 10.1016/S0140-6736(05)66585-3

Di Angelantonio, 2009, Major lipids, apolipoproteins, and risk of vascular disease, JAMA, 302, 1993, 10.1001/jama.2009.1619

Ding, 2009, Sex hormone-binding globulin and risk of type 2 diabetes in women and men, The New England Journal of Medicine, 361, 1152, 10.1056/NEJMoa0804381

Sattar, 2006, Adiponectin and coronary heart disease: a prospective study and meta-analysis, Circulation, 114, 623, 10.1161/CIRCULATIONAHA.106.618918

McConway, 2000, Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans, Annals of Clinical Biochemistry, 37, 717, 10.1258/0004563001899771

Cook, 2010, Hypoadiponectinemia–cause or consequence of human “insulin resistance”?, The Journal of Clinical Endocrinology and Metabolism, 95, 1544, 10.1210/jc.2009-2286

Wilkin, 2006, The gender insulin hypothesis: why girls are born lighter than boys, and the implications for insulin resistance, International Journal of Obesity (London)., 30, 1056, 10.1038/sj.ijo.0803317

Ehtisham, 2004, The emergence of type 2 diabetes in childhood, Annals of Clinical Biochemistry, 41, 10, 10.1258/000456304322664654

Moran, 1999, Insulin resistance during puberty: results from clamp studies in 357 children, Diabetes, 48, 2039, 10.2337/diabetes.48.10.2039

Tillin, 2013, Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent REvisited (SABRE) cohort, Diabetes Care, 36, 383, 10.2337/dc12-0544

Lovejoy, 2009, Sex differences in obesity and the regulation of energy homeostasis, Obesity Reviews, 10, 154, 10.1111/j.1467-789X.2008.00529.x

Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, The New England Journal of Medicine, 346, 393, 10.1056/NEJMoa012512

Jebb, 2011, Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial, Lancet, 378, 1485, 10.1016/S0140-6736(11)61344-5